Open Access

Cancer immunotherapy with CAR T cells: well-trodden paths and journey along lesser-known routes

Anze Smole

Anze Smole

Immunology and Cellular Immunotherapy (ICI) Group, Department of Genetic Toxicology and Cancer Biology, National Institute of BiologyLjubljana, Slovenia
Search for this author on
Sciendo|Google Scholar
Smole, Anze
  
Dec 13, 2022
Cancer immunotherapy with CAR T cells: well-trodden paths and journey along lesser-known routes's Cover Image
About this article
Previous Article
Next Article
Cite
Download Cover
Article Category: review
Published Online: Dec 13, 2022
Page range: 409 - 419
Received: Oct 19, 2022
Accepted: Oct 27, 2022
DOI: https://doi.org/10.2478/raon-2022-0049
Keywords
© 2022 Anze Smole, published by Sciendo
This work is licensed under the Creative Commons Attribution 4.0 International License.
Smole, Anze
Immunology and Cellular Immunotherapy (ICI) Group, Department of Genetic Toxicology and Cancer Biology, National Institute of BiologyLjubljana, Slovenia
Language:
English
Publication timeframe:
4 times per year
Journal Subjects:
Medicine, Clinical Medicine, Internal Medicine, Haematology, Oncology, Radiology
Journal RSS Feed